Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis

Pharmacology and Therapeutics

Volumn 164, Issue , 2016, Pages 144-151

  Sivaprakasam, Sathish ^a   Prasad, Puttur D ^a   Singh, Nagendra ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Dietary fibers; Gut microbiota; Inflammation and cancer; Short chain fatty acid receptors; Short chain fatty acids

Indexed keywords

ACETIC ACID; BUTYRIC ACID; CELL RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 109A; G PROTEIN COUPLED RECEPTOR 41; G PROTEIN COUPLED RECEPTOR 43; PROPIONIC ACID; SHORT CHAIN FATTY ACID; SHORT CHAIN FATTY ACID RECEPTOR; UNCLASSIFIED DRUG; ACETIC ACID DERIVATIVE; BUTYRIC ACID DERIVATIVE; CELL SURFACE RECEPTOR; FFAR3 PROTEIN, HUMAN; G-PROTEIN COUPLED RECEPTOR 43, HUMAN; HCAR2 PROTEIN, HUMAN; NICOTINIC RECEPTOR; PROPIONIC ACID DERIVATIVE; VOLATILE FATTY ACID;

CARBOHYDRATE INTAKE; CARCINOGENESIS; DIETARY FIBER; ENTERITIS; FERMENTATION; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; INTESTINE CANCER; INTESTINE EPITHELIUM; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; INFLAMMATION; INTESTINE TUMOR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACETATES; ANIMALS; BUTYRATES; CARCINOGENESIS; DIETARY FIBER; FATTY ACIDS, VOLATILE; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; INTESTINAL NEOPLASMS; PROPIONATES; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC;

EID: 84964929933     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2016.04.007     Document Type: Review

References (104)

1. Ahmed, K., Tunaru, S., Offermanns, S., GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends Pharmacol Sci 30 (2009), 557–562.
2. Ang, Z., Er, J.Z., Ding, J.L., The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes. Sci Rep, 5, 2015, 8134.
3. Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P. Rudensky, A.Y., Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504 (2013), 451–455.
4. Backhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., Gordon, J.I., Host-bacterial mutualism in the human intestine. Science 307 (2005), 1915–1920.
5. Belenguer, A., Duncan, S.H., Calder, A.G., Holtrop, G., Louis, P., Lobley, G.E., Flint, H.J., Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72 (2006), 3593–3599.
6. Bellahcene, M., O'Dowd, J.F., Wargent, E.T., Zaibi, M.S., Hislop, D.C., Ngala, R.A., Smith, D.M., Cawthorne, M.A., Stocker, C.J., Arch, J.R., Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. Br J Nutr 109 (2013), 1755–1764.
7. Bergman, E.N., Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70 (1990), 567–590.
8. Bjursell, M., Admyre, T., Goransson, M., Marley, A.E., Smith, D.M., Oscarsson, J., Bohlooly, Y.M., Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am J Physiol Endocrinol Metab 300 (2011), E211–E220.
9. Bolognini, D., Tobin, A.B., Milligan, G., Moss, C.E., The pharmacology and function of receptors for short-chain fatty acids. Mol Pharmacol 89 (2016), 388–398.
10. Brown, A.J., Goldsworthy, S.M., Barnes, A.A., Eilert, M.M., Tcheang, L., Daniels, D. Dowell, S.J., The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278 (2003), 11312–11319.
11. Carding, S., Verbeke, K., Vipond, D.T., Corfe, B.M., Owen, L.J., Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis, 26, 2015, 26191.
12. Charney, A.N., Micic, L., Egnor, R.W., Nonionic diffusion of short-chain fatty acids across rat colon. Am J Phys 274 (1998), G518–G524.
13. Chen, H., Assmann, J.C., Krenz, A., Rahman, M., Grimm, M., Karsten, C.M. Schwaninger, M., Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. J Clin Invest 124 (2014), 2188–2192.
14. Chow, J., Tang, H., Mazmanian, S.K., Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol 23 (2011), 473–480.
15. Coombes, J.L., Siddiqui, K.R., Arancibia-Carcamo, C.V., Hall, J., Sun, C.M., Belkaid, Y., Powrie, F., A functionally specialized population of mucosal CD103 + DCs induces Foxp3 + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204 (2007), 1757–1764.
16. Cornall, L.M., Mathai, M.L., Hryciw, D.H., McAinch, A.J., The therapeutic potential of GPR43: a novel role in modulating metabolic health. Cell Mol Life Sci 70 (2013), 4759–4770.
17. Cresci, G., Nagy, L.E., Ganapathy, V., Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury. J Parenter Enter Nutr 37 (2013), 763–774.
18. Cresci, G.A., Thangaraju, M., Mellinger, J.D., Liu, K., Ganapathy, V., Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8. J Gastrointest Surg 14 (2010), 449–461.
19. Cummings, J.H., Pomare, E.W., Branch, W.J., Naylor, C.P., Macfarlane, G.T., Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28 (1987), 1221–1227.
20. Dupaul-Chicoine, J., Yeretssian, G., Doiron, K., Bergstrom, K.S., McIntire, C.R., LeBlanc, P.M. Saleh, M., Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32 (2010), 367–378.
21. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M. Relman, D.A., Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
22. Elangovan, S., Pathania, R., Ramachandran, S., Ananth, S., Padia, R.N., Lan, L. Thangaraju, M., The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. Cancer Res 74 (2014), 1166–1178.
23. Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J. Flavell, R.A., NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145 (2011), 745–757.
24. Eswaran, S., Muir, J., Chey, W.D., Fiber and functional gastrointestinal disorders. Am J Gastroenterol 108 (2013), 718–727.
25. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B. Cani, P.D., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110 (2013), 9066–9071.
26. Faith, J.J., Guruge, J.L., Charbonneau, M., Subramanian, S., Seedorf, H., Goodman, A.L. Gordon, J.I., The long-term stability of the human gut microbiota. Science, 341, 2013, 1237439.
27. Falony, G., Vlachou, A., Verbrugghe, K., De Vuyst, L., Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 72 (2006), 7835–7841.
28. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104 (2007), 13780–13785.
29. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D. Ohno, H., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450.
30. Gaidarov, I., Chen, X., Anthony, T., Maciejewski-Lenoir, D., Liaw, C., Unett, D.J., Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential. Cell Signal 25 (2013), 2003–2016.
31. Ganapathy, V., Thangaraju, M., Prasad, P.D., Martin, P.M., Singh, N., Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol 13 (2013), 869–874.
32. Garrett, W.S., Gallini, C.A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney, M.L. Glimcher, L.H., Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8 (2010), 292–300.
33. Garrett, W.S., Lord, G.M., Punit, S., Lugo-Villarino, G., Mazmanian, S.K., Ito, S. Glimcher, L.H., Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131 (2007), 33–45.
34. Gibson, G.R., Scott, K.P., Rastall, R.A., Tuohy, K.M., Hotchkiss, A., Dubert-Ferrandon, A. Buddington, R., Dietary prebiotics: current status and new definition. Food Sci Tech Bull - Funct Foods 7 (2010), 1–19.
35. Grice, E.A., Segre, J.A., The human microbiome: our second genome. Annu Rev Genomics Hum Genet 13 (2012), 151–170.
36. Hadjiagapiou, C., Schmidt, L., Dudeja, P.K., Layden, T.J., Ramaswamy, K., Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1. Am J Physiol Gastrointest Liver Physiol 279 (2000), G775–G780.
37. Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., Brummer, R.J., Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27 (2008), 104–119.
38. Hansen, L., Skeie, G., Landberg, R., Lund, E., Palmqvist, R., Johansson, I. Olsen, A., Intake of dietary fiber, especially from cereal foods, is associated with lower incidence of colon cancer in the HELGA cohort. Int J Cancer 131 (2012), 469–478.
39. Hegyi, J., Schwartz, R.A., Hegyi, V., Pellagra: dermatitis, dementia, and diarrhea. Int J Dermatol 43 (2004), 1–5.
40. Hong, Y.H., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C. Sasaki, S., Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146 (2005), 5092–5099.
41. Hou, J.K., Abraham, B., El-Serag, H., Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106 (2011), 563–573.
42. Huber, S., Gagliani, N., Esplugues, E., O'Connor, W. Jr., Huber, F.J., Chaudhry, A. Flavell, R.A., Th17 cells express interleukin-10 receptor and are controlled by Foxp3(−) and Foxp3 + regulatory CD4 + T cells in an interleukin-10-dependent manner. Immunity 34 (2011), 554–565.
43. Izcue, A., Coombes, J.L., Powrie, F., Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 27 (2009), 313–338.
44. Kaji, I., Karaki, S., Kuwahara, A., Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release. Digestion 89 (2014), 31–36.
45. Karaki, S., Mitsui, R., Hayashi, H., Kato, I., Sugiya, H., Iwanaga, T. Kuwahara, A., Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res 324 (2006), 353–360.
46. Karaki, S., Tazoe, H., Hayashi, H., Kashiwabara, H., Tooyama, K., Suzuki, Y., Kuwahara, A., Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol 39 (2008), 135–142.
47. Kim, M.H., Kang, S.G., Park, J.H., Yanagisawa, M., Kim, C.H., Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology, 145(396–406), 2013, e1-10.
48. Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T. Tsujimoto, G., The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun, 4, 2013, 1829.
49. Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M. Garrett, W.S., Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14 (2013), 207–215.
50. Le Bourgot, C., Ferret-Bernard, S., Le Normand, L., Savary, G., Menendez-Aparicio, E., Blat, S. Le Huerou-Luron, I., Maternal short-chain fructooligosaccharide supplementation influences intestinal immune system maturation in piglets. PLoS One, 9, 2014, e107508.
51. Le Poul, E., Loison, C., Struyf, S., Springael, J.Y., Lannoy, V., Decobecq, M.E. Detheux, M., Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278 (2003), 25481–25489.
52. Lee, Y.K., Mazmanian, S.K., Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 330 (2010), 1768–1773.
53. Lee, S.U., In, H.J., Kwon, M.S., Park, B.O., Jo, M., Kim, M.O. Kim, S., beta-Arrestin 2 mediates G protein-coupled receptor 43 signals to nuclear factor-kappaB. Biol Pharm Bull 36 (2013), 1754–1759.
54. Ley, R.E., Obesity and the human microbiome. Curr Opin Gastroenterol 26 (2010), 5–11.
55. Li, Y., Kokrashvili, Z., Mosinger, B., Margolskee, R.F., Gustducin couples fatty acid receptors to GLP-1 release in colon. Am J Physiol Endocrinol Metab 304 (2013), E651–E660.
56. Liu, B., Tonkonogy, S.L., Sartor, R.B., Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. Gastroenterology 141 (2011), 653–662 (662 e651–654).
57. Lukasova, M., Malaval, C., Gille, A., Kero, J., Offermanns, S., Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 121 (2011), 1163–1173.
58. Macia, L., Tan, J., Vieira, A.T., Leach, K., Stanley, D., Luong, S. Mackay, C.R., Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun, 6, 2015, 6734.
59. Mascolo, N., Rajendran, V.M., Binder, H.J., Mechanism of short-chain fatty acid uptake by apical membrane vesicles of rat distal colon. Gastroenterology 101 (1991), 331–338.
60. Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D. Mackay, C.R., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 (2009), 1282–1286.
61. Mazmanian, S.K., Round, J.L., Kasper, D.L., A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008), 620–625.
62. Nagano, Y., Itoh, K., Honda, K., The induction of Treg cells by gut-indigenous Clostridium. Curr Opin Immunol 24 (2012), 392–397.
63. Nicholson, J.K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., Pettersson, S., Host-gut microbiota metabolic interactions. Science 336 (2012), 1262–1267.
64. Offermanns, S., Schwaninger, M., Nutritional or pharmacological activation of HCA(2) ameliorates neuroinflammation. Trends Mol Med 21 (2015), 245–255.
65. O'Hara, A.M., Shanahan, F., The gut flora as a forgotten organ. EMBO Rep 7 (2006), 688–693.
66. O'Keefe, S.J., Li, J.V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K. Zoetendal, E.G., Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun, 6, 2015, 6342.
67. Palmer, R., Fecal matters. Nat Med 17 (2011), 150–152.
68. Poutahidis, T., Cappelle, K., Levkovich, T., Lee, C.W., Doulberis, M., Ge, Z., Fox, J.G., Horwitz, B.H., Erdman, S.E., Pathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice. PloS one, 8, 2013, e73933.
69. Rahman, M., Muhammad, S., Khan, M.A., Chen, H., Ridder, D.A., Muller-Fielitz, H. Schwaninger, M., The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun, 5, 2014, 3944.
70. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R., Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004), 229–241.
71. Roediger, W.E., Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83 (1982), 424–429.
72. Rubtsov, Y.P., Rasmussen, J.P., Chi, E.Y., Fontenot, J., Castelli, L., Ye, X. Rudensky, A.Y., Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28 (2008), 546–558.
73. Rudolph, U., Finegold, M.J., Rich, S.S., Harriman, G.R., Srinivasan, Y., Brabet, P. Birnbaumer, L., Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet 10 (1995), 143–150.
74. Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K. Gordon, J.I., Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 105 (2008), 16767–16772.
75. Schatzkin, A., Mouw, T., Park, Y., Subar, A.F., Kipnis, V., Hollenbeck, A. Thompson, F.E., Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr 85 (2007), 1353–1360.
76. Sekirov, I., Russell, S.L., Antunes, L.C., Finlay, B.B., Gut microbiota in health and disease. Physiol Rev 90 (2010), 859–904.
77. Shanahan, F., Quigley, E.M., Manipulation of the microbiota for treatment of IBS and IBD—challenges and controversies. Gastroenterology 146 (2014), 1554–1563.
78. Sina, C., Gavrilova, O., Forster, M., Till, A., Derer, S., Hildebrand, F. Rosenstiel, P., G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol 183 (2009), 7514–7522.
79. Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H. Ganapathy, V., Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40 (2014), 128–139.
80. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M. Garrett, W.S., The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
81. Stoddart, L.A., Smith, N.J., Jenkins, L., Brown, A.J., Milligan, G., Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids. J Biol Chem 283 (2008), 32913–32924.
82. Sun, C.M., Hall, J.A., Blank, R.B., Bouladoux, N., Oukka, M., Mora, J.R., Belkaid, Y., Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204 (2007), 1775–1785.
83. Taggart, A.K., Kero, J., Gan, X., Cai, T.Q., Cheng, K., Ippolito, M. Waters, M.G., (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 280 (2005), 26649–26652.
84. Tang, C., Ahmed, K., Gille, A., Lu, S., Grone, H.J., Tunaru, S., Offermanns, S., Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nat Med 21 (2015), 173–177.
85. Tang, Y., Chen, Y., Jiang, H., Robbins, G.T., Nie, D., G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int J Cancer 128 (2011), 847–856.
86. Tazoe, H., Otomo, Y., Karaki, S., Kato, I., Fukami, Y., Terasaki, M., Kuwahara, A., Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed Res 30 (2009), 149–156.
87. Thangaraju, M., Carswell, K.N., Prasad, P.D., Ganapathy, V., Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem J 417 (2009), 379–389.
88. Thangaraju, M., Cresci, G., Itagaki, S., Mellinger, J., Browning, D.D., Berger, F.G. Ganapathy, V., Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J Gastrointest Surg 12 (2008), 1773–1781 (discussion 1781–1772).
89. Thangaraju, M., Cresci, G.A., Liu, K., Ananth, S., Gnanaprakasam, J.P., Browning, D.D. Ganapathy, V., GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 69 (2009), 2826–2832.
90. Thorburn, A.N., Macia, L., Mackay, C.R., Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity 40 (2014), 833–842.
91. Tolhurst, G., Heffron, H., Lam, Y.S., Parker, H.E., Habib, A.M., Diakogiannaki, E. Gribble, F.M., Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61 (2012), 364–371.
92. Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C. Marsland, B.J., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20 (2014), 159–166.
93. Tsai, F., Coyle, W.J., The microbiome and obesity: is obesity linked to our gut flora?. Curr Gastroenterol Rep 11 (2009), 307–313.
94. Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K., Offermanns, S., PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9 (2003), 352–355.
95. Tunaru, S., Lattig, J., Kero, J., Krause, G., Offermanns, S., Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G). Mol Pharmacol 68 (2005), 1271–1280.
96. Turnbaugh, P.J., Backhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
97. Van Immerseel, F., Ducatelle, R., De Vos, M., Boon, N., Van De Wiele, T., Verbeke, K. Flint, H.J., Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J Med Microbiol 59 (2010), 141–143.
98. Vieira, A.T., Macia, L., Galvao, I., Martins, F.S., Canesso, M.C., Amaral, F.A. Mackay, C.R., A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis Rheumatol 67 (2015), 1646–1656.
99. Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S. Gewirtz, A.T., Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328 (2010), 228–231.
100. Walters, R.W., Shukla, A.K., Kovacs, J.J., Violin, J.D., DeWire, S.M., Lam, C.M. Lefkowitz, R.J., beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J Clin Invest 119 (2009), 1312–1321.
101. Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X. Zhao, L., Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 6 (2012), 320–329.
102. Zaki, M.H., Boyd, K.L., Vogel, P., Kastan, M.B., Lamkanfi, M., Kanneganti, T.D., The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32 (2010), 379–391.
103. Zaki, M.H., Vogel, P., Body-Malapel, M., Lamkanfi, M., Kanneganti, T.D., IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol 185 (2010), 4912–4920.
104. Zambell, K.L., Fitch, M.D., Fleming, S.E., Acetate and butyrate are the major substrates for de novo lipogenesis in rat colonic epithelial cells. J Nutr 133 (2003), 3509–3515.